SCHEMBL2065491

SCHEMBL2065491

O=C(O)c1ccc(-c2cc(Cl)c(C(C3CCNC3=O)N3CCCCC3)c(Cl)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 4/20 0.41
PDE5A O76074 3/20 0.41
PDE1A P54750 3/20 0.41
PDE1B Q01064 3/20 0.41
PDE7A Q13946 3/20 0.41
PDE1C Q14123 3/20 0.41
PDE3A Q14432 3/20 0.41
RXRA P19793 4/20 0.37
RXRB P28702 4/20 0.37
TDP1 Q9NUW8 2/20 0.36
TP53 P04637 1/20 0.35
OPRD1 P41143 1/20 0.34
SLC6A4 P31645 3/20 0.33
SLC6A3 Q01959 3/20 0.33
PDE4A P27815 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE4C Q08493 2/20 0.33
ALDH1A1 P00352 1/20 0.33
SLC6A2 P23975 2/20 0.33
HRH3 Q9Y5N1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4181004 0.94 PDE4D (0.39) PDE4DPDE5APDE1APDE1BPDE7A
SCHEMBL2065311 0.88 ALDH1A1 (0.40) OPRD1SLC6A4SLC6A3ALDH1A1SLC6A2
Trifluoroacetic Acid SCHEMBL4185040 0.85 DPP4 (0.37) PDE4DPDE5APDE1APDE1BPDE7A
SCHEMBL1092157 0.83 PDE4D (0.32) PDE4DPDE5APDE1APDE1BPDE7A
SCHEMBL209307 0.82 PDE4D (0.41) PDE4DPDE5APDE1APDE1BPDE7A
SCHEMBL4183985 0.82 ALDH1A1 (0.40) OPRD1SLC6A4SLC6A3ALDH1A1SLC6A2
SCHEMBL1092830 0.76 LIPC (0.38) TDP1TP53HRH3
SCHEMBL2988655 0.76 PDE4D (0.38) PDE4DPDE5APDE1APDE1BPDE7A
SCHEMBL4067647 0.76 POLB (0.37) PDE4DPDE5APDE1APDE1BPDE7A
SCHEMBL2993023 0.75 PDE4D (0.37) PDE4DPDE5APDE1APDE1BPDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016071-B1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-07-24 EP disclosed
US-8148534-B2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-04-03 US disclosed
US-20090275613-A1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275613-A1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD11B2, HSD3B1 PDE4D 783/4885PDE5A 290/4885PDE1A 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.